MagnoVision MG10

MagnoVision MG10 is a non-invasive electromagnetic stimulation and neuromodulation device applied via a specially designed helmet, without touching the eyeball. The 9 magnetic coils in the helmet create a safe electromagnetic field at 42 Hz frequency and 2,000 milligauss intensity, simultaneously stimulating the retina, optic nerve and visual pathways. Through neuromodulation, iontophoresis and increased growth-factor activity, it raises the tissue level of reparative neurotrophic growth factors, growth factor–receptor sensitivity, synaptic transmission and blood flow. It can therefore be used alone or in combination with therapies such as stem cells or anti-VEGF in dystrophic, neurodegenerative, ischemic and traumatic retinal/optic nerve diseases that cannot be adequately treated with existing methods. Main applications include retinitis pigmentosa, toxic optic neuropathy, dense vitreous/preretinal/subretinal hemorrhages, age-related macular degeneration, various maculopathies and optic nerve damage due to glaucoma. The treatment parameters (field intensity, frequency, duration) are fixed and cannot be changed by the patient or user; treatment is performed under specialist supervision, in a seated position, effortlessly, and each session lasts 30 minutes. The generated magnetic field is well below the World Health Organization (WHO) safety limits, and no complications or side effects have been reported in published case series. The device was developed by Bioretina Biotechnology at Ankara University Technopark, is CE certified and has been used in Phase 3 clinical trials.